Who are enhanced DefenAge 8-in-1 BioSerum's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/enhanced-defenage-8-in-1-bioserum.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

enhanced DefenAge 8-in-1 BioSerum — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

enhanced DefenAge 8-in-1 BioSerum (enhanced DefenAge 8-in-1 BioSerum) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: topical anti-aging agent. Area: Dermatology.

phase 3 topical anti-aging agent Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

enhanced DefenAge 8-in-1 BioSerum (enhanced DefenAge 8-in-1 BioSerum) — Goldman, Butterwick, Fitzpatrick and Groff. Enhanced DefenAge 8-in-1 BioSerum is a topical serum that targets multiple signs of aging through a combination of peptides, growth factors, and other bioactive molecules.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
enhanced DefenAge 8-in-1 BioSerum TARGET	enhanced DefenAge 8-in-1 BioSerum	Goldman, Butterwick, Fitzpatrick and Groff	phase 3	topical anti-aging agent

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (topical anti-aging agent class)

Goldman, Butterwick, Fitzpatrick and Groff · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). enhanced DefenAge 8-in-1 BioSerum — Competitive Intelligence Brief. https://druglandscape.com/ci/enhanced-defenage-8-in-1-bioserum. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab